Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We reiterate our long-term Neutral recommendation on JDS Uniphase Corp. (JDSU - Analyst Report). The company posted mixed financial results for the first quarter of fiscal 2013. Although the revenue fell below the Zacks Consensus Estimate, net income topped the same. The company’s newly launched products accounted for 57% of its total revenue in core network market. However, overall book-to-bill ratio remained less than 1.0 throughout the quarter. We remain concerned regarding the delay in carrier order due to a volatile global macro-economy.
Consolidation trend in the optical gear manufacturing industry as well as in the telecom carrier industry may act as a spoiler for the optical component suppliers, such as JDS Uniphase. Nevertheless, its newly launched differentiated products, which are gaining encouraging market traction coupled with acquisitions of Dyaptive and GenComm may become long-term positives for the company.
Next-generation 4G Long-Term Evolution (LTE) networks became a major growth driver for JDS Uniphase. The company offers an innovative LTE test solution, which encompasses end-to-end, real-time tracing, data assurance, and OSS to derive the performance and revenue potential of LTE.
Meanwhile, the optical component industry is going through a downtrend. Major telecom carriers are making inventory correction and this scenario is expected to continue till the end of 2012. The company’s closest rivals, such as Ciena Corp. (CIEN - Analyst Report), Finisar Corp. (FNSR - Snapshot Report), and Oclaro Inc. (OCLR - Snapshot Report) are all suffering from industry headwinds. Several industry players estimated that demand from the largest emerging market of China will not meet expectations. JDS Uniphase is highly dependent on China since the developed western world is still reeling under economic headwinds.
Read the full reports :
Analyst Report on CIEN
Snapshot Report on FNSR
Analyst Report on JDSU
Snapshot Report on OCLR